Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedules.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples